Position in CYTK
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$32,955,000
+$23,594,218 QoQ
Shares Held
500,000
+158.8% QoQ
Ownership
0.360%
of shares outstanding
% of Portfolio
2.54%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CYTK Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MPM BIOIMPACT LLC holds $1,463,416,616 across 34 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CGEM |
Cullinan Therapeutics, Inc.
|
9,731,341 | $177,207,719 | |
| 2 | AKTS |
Aktis Oncology, Inc.
|
4,835,872 | $155,860,154 | |
| 3 | RVMD |
Revolution Medicines, Inc.
|
492,483 | $92,232,216 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
771,028 | $67,040,884 | |
| 5 | EWTX |
Edgewise Therapeutics, Inc.
|
1,620,780 | $65,852,291 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,122,731 | $63,782,348 | |
| 7 | DBVT |
DBV Technologies S.A.
|
3,666,284 | $60,127,057 | |
| 8 | TRVI |
Trevi Therapeutics, Inc.
|
3,073,577 | $57,322,211 |
All Filings in CYTK
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $32,955,000 | 500,000 | Shares | Sole | 2026-05-15 | |
| 2022-09-30 | $9,360,782 | 193,205 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,631,925 | 194,246 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $8,254,495 | 224,246 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $10,586,775 | 232,268 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $8,838,180 | 247,291 | Shares | Sole | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||